Superselective Ophthalmic Artery Chemotherapy as Primary Treatment for Retinoblastoma (Chemosurgery)
Authors:
- David H. AbramsonDADavid H. Abramson
- Ira J. DunkelIDIra J. Dunkel
- Scott E. BrodieSBScott E. Brodie
- Brian MarrBMBrian Marr
- Y. Pierre GobinYGY. Pierre Gobin
- 1 August 2010
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 117 (8) , 1623-1629
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservationBritish Journal of Ophthalmology, 2009
- Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastomaDocumenta Ophthalmologica, 2009
- Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastomaPediatric Blood & Cancer, 2009
- Fibrin Sealant for Retinoblastoma: Where Are We?Journal of Ocular Pharmacology and Therapeutics, 2008
- Ischemic Necrosis and Atrophy of the Optic Nerve After Periocular Carboplatin Injection for Intraocular RetinoblastomaAmerican Journal of Ophthalmology, 2006
- Assessment of hearing in very young children receiving carboplatin for retinoblastomaEuropean Journal of Cancer, 2006
- UPDATE ON RETINOBLASTOMARetina, 2004
- Pharmacokinetics of Systemic Versus Focal Carboplatin Chemotherapy in the Rabbit Eye: Possible Implication in the Treatment of RetinoblastomaInvestigative Ophthalmology & Visual Science, 2004
- The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastomaInternational Journal of Clinical Oncology, 2004
- A phase I/II study of subconjunctival carboplatin for intraocular retinoblastomaOphthalmology, 1999